InSite Vision Inc, Merck, Novartis, Pfizer ophthalmic news

The U.S. District Court for the District of New Jersey ruled in favor of Merck, Pfizer and InSite in InSite Vision Inc. et al. vs. Sandoz Inc.

Read the full 272 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE